Why Editas Medicine, Inc. (EDIT) stock fell 9.6% on Tuesday, November 10, 2026

Editas Medicine, Inc. (EDIT) traded at $2.49 as of 11:31 AM ET, down 9.64% on Tuesday, November 10, 2026, on volume of 898,823 shares (0.3× its 3-month average); market value about $400.0M.

What happened: primary sources

Events Nexqual found for EDIT on Tuesday, November 10, 2026 or the trading day before (November 9, 2026):

• Nov 9, 2026: Reported Q3 2026 results: EPS −$0.15 vs consensus −$0.21 (beat), revenue $10.4M vs consensus $4.5M (beat). Guidance: The Company expects that its existing cash, cash equivalents, and marketable securities will enable the Company to fund its operating expenses and capital expenditure requirements into the second half of 2028. source

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on EDIT

EDIT stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: EDIT results, November 9, 2026. Other big moves that day: November 10, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:31 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:31 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt